Drug · CHEMBL55643

COPPER

7 sourcespipelines-2026-09-18-0.3.1

Cite this record

ConductScience Library. COPPER. Drugs and targets, record CHEMBL55643. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL55643

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name: COPPER; ChEMBL
ChEMBL ID: CHEMBL55643; ChEMBL
Type: Small molecule; ChEMBL
Brand names: Cosmetic bronze powder vp-1, Cosmetic copper powder vp-1, Cu-7, Paragard t 380a, Tatum-t; ChEMBL
Other names: Bronze powder, C.i. 77400, C.i. pigment metal, Ci 77400, Copper powder, Copper, elemental, Copper, metallic, Cuprum metallicum; ChEMBL
Open Targets' highest stage: Approval, for 1 of its 7 diseases, from TTD; Open Targets

Targets0

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

None in this release.

Diseases7

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Disease	Open Targets' stage	Stage reported by	Reports	Of them trials	Its drugs
contraception	Approval	TTD	4	3	https://conductscience.org/library/drugs?q=EFO_0009520
glioblastoma	Phase 2/3	ClinicalTrials.gov	3	3	https://conductscience.org/library/drugs?q=MONDO_0018177
breast cancer	Phase 2	ClinicalTrials.gov	2	2	https://conductscience.org/library/drugs?q=MONDO_0007254
Wilson disease	Unknown	ClinicalTrials.gov	1	1	https://conductscience.org/library/drugs?q=MONDO_0010200
amyotrophic lateral sclerosis	Phase 1/2	ClinicalTrials.gov	1	1	https://conductscience.org/library/drugs?q=MONDO_0004976
osteoarthritis	Phase 1/2	ClinicalTrials.gov	1	1	https://conductscience.org/library/drugs?q=MONDO_0005178
overactive bladder	Investigational new drug	TTD	1	0	https://conductscience.org/library/drugs?q=MONDO_0006624

Source Open Targets

Trials25

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 6 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 8 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.

Trial	Title	Phase	Participants	Results first posted	Named as	Linked by	Source
NCT03124160	Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard	Phase 3	1,105	2024-09-25	copper intrauterine device	Open Targets' reading, confirmed by the trial's result groups	ClinicalTrials.gov
NCT01299116	Long-Acting Reversible Contraception	Phase 4	916	2018-01-26	copper intrauterine device	Open Targets' reading, confirmed by the trial's result groups	ClinicalTrials.gov
NCT02615249	Clinical Evaluation of Metal Panel Allergens: Dose Response Study	Phase 2	122	2020-08-11	copper	Its name	ClinicalTrials.gov
NCT00669396	Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception		57	2009-08-06	copper t380 intrauterine device	Open Targets' reading, confirmed by the trial's result groups	ClinicalTrials.gov
NCT01240811	Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception		42	2013-07-22	copper t380a	Open Targets' reading, confirmed by the trial's result groups	ClinicalTrials.gov
NCT02715609	Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma	Phase 1/2	35	2025-04-10	copper	Its name	ClinicalTrials.gov
NCT04022915	PET Fibrin Imaging of DVT and PE	Phase 1	6	2026-03-18	copper	Its name	ClinicalTrials.gov
NCT02763215	The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment		64	2020-10-26	copper chelator	Open Targets' reading, confirmed by the trial's result groups	ClinicalTrials.gov
NCT02550067	The Evidence for Contraceptive Options and HIV Outcomes Trial		7,830		copper	Its name	ClinicalTrials.gov
NCT07264933	Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation		750		copper T380A intrauterine device	Open Targets' reading, confirmed by NLM's indexing of its papers	ClinicalTrials.gov

1 to 10 of 25

See all 25 trials

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

None in this release.

Papers from its trials20

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it	Source
42890951	DERIVED	1	PubMed
41000288	DERIVED	1	PubMed
39085989	DERIVED	1	PubMed
38768767	DERIVED	1	PubMed
38459552	DERIVED	1	PubMed
37000452	DERIVED	1	PubMed
35972853	DERIVED	1	PubMed
35941737	DERIVED	1	PubMed
35669313	DERIVED	1	PubMed
35657948	DERIVED	1	PubMed

1 to 10 of 20

See all 20 papers from its trials

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
ClinicalTrials.gov: 2026-11-05; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
Papers the trials list, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
Tests named in the trials, as ScienceGraph matched them: 2026-11-12; ConductCognition

Sources 7

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ConductCognition's list of its testsOur own data
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL55643

GET https://conductscience.org/api/drugs/v1/CHEMBL55643/trials?page=2

API reference For AI assistants